SineuGene Therapeutics receives US FDA’s investigational new drug application clearance for SNUG01 to treat amyotrophic lateral sclerosis: Beijing Thursday, March 27, 2025, 15:0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback